DEUTSCHE BANK AG\ - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 49 filers reported holding MEI PHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2022$37,000
-80.1%
62,583
-10.2%
0.00%
Q4 2021$186,000
+1.6%
69,700
+5.2%
0.00%
Q3 2021$183,000
-15.7%
66,224
-13.1%
0.00%
Q2 2021$217,000
-14.6%
76,216
+2.8%
0.00%
Q1 2021$254,000
+19.2%
74,143
-8.2%
0.00%
Q4 2020$213,000
+9.8%
80,807
+30.0%
0.00%
Q3 2020$194,000
-9.3%
62,176
+19.9%
0.00%
Q2 2020$214,000
+269.0%
51,851
+44.2%
0.00%
Q1 2020$58,000
-13.4%
35,967
+31.0%
0.00%
Q4 2019$67,000
-18.3%
27,454
-44.7%
0.00%
Q3 2019$82,000
-77.7%
49,647
-66.5%
0.00%
Q2 2019$368,000
+418.3%
148,184
+529.6%
0.00%
Q1 2019$71,000
-87.1%
23,536
-88.7%
0.00%
Q4 2018$549,000
-65.8%
208,113
-44.1%
0.00%
Q3 2018$1,603,000
-18.7%
372,156
-25.6%
0.00%
-100.0%
Q2 2018$1,971,000
+428.4%
500,326
+177.6%
0.00%
Q1 2018$373,000
-22.0%
180,213
-20.9%
0.00%
Q4 2017$478,000
+12.2%
227,932
+43.1%
0.00%
Q3 2017$426,000
-4.5%
159,241
-14.8%
0.00%
Q2 2017$446,000
+107.4%
186,813
+40.5%
0.00%
Q1 2017$215,000
+593.5%
132,959
+510.5%
0.00%
Q4 2016$31,000
-93.3%
21,778
-91.7%
0.00%
Q3 2016$460,000
+15233.3%
261,447
+10100.8%
0.00%
Q2 2016$3,000
-25.0%
2,563
-30.5%
0.00%
Q1 2016$4,0000.0%3,686
+47.4%
0.00%
Q4 2015$4,000
-84.6%
2,501
-85.4%
0.00%
Q3 2015$26,000
+550.0%
17,085
+583.4%
0.00%
Q2 2015$4,000
-88.9%
2,500
-87.7%
0.00%
Q1 2015$36,000
-85.9%
20,370
-66.3%
0.00%
Q4 2014$256,000
-38.5%
60,3700.0%0.00%
Q3 2014$416,000
+51.3%
60,370
+38.9%
0.00%
Q2 2014$275,000
+21.7%
43,478
+112.7%
0.00%
Q1 2014$226,000
+133.0%
20,445
+66.8%
0.00%
Q4 2013$97,000
-59.4%
12,258
-42.5%
0.00%
Q3 2013$239,00021,3320.00%
Other shareholders
MEI PHARMA INC shareholders Q4 2013
NameSharesValueWeighting ↓
Burrage Capital Management LLC 3,039,038$9,482,0007.48%
Asymmetry Capital Management, L.P. 787,359$2,457,0001.58%
First Light Asset Management, LLC 3,763,804$11,743,0001.20%
NEA Management Company, LLC 8,533,072$26,623,0001.13%
Opaleye Management Inc. 1,556,000$4,855,0000.95%
BVF INC/IL 4,080,162$12,730,0000.69%
DAFNA Capital Management LLC 666,000$2,078,0000.68%
CAXTON CORP 175,560$548,0000.52%
Alambic Investment Management, L.P. 12,500$39,0000.43%
Boxer Capital, LLC 2,913,091$9,089,0000.31%
View complete list of MEI PHARMA INC shareholders